Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Spero Therapeutics will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City, with the company presentation scheduled for September 15, 2026 at 1:30 PM ET. President and CEO Esther Rajavelu will deliver the presentation, and Spero's leadership team will be available for one-on-one meetings; a webcast with an approximately 90-day replay will be accessible via the company's website.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.